Tag: biotechnology
-
Biotech Start-Up Begins Longevity Therapy Work
A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process.
-
Gates Funds Engineered Malaria Mosquito Pilot Test
A developer of genetically altered insects designed to destroy disease-spreading colonies is set to begin pilot tests of its anti-malarial mosquito line.
-
Preclinical Tests Show Antibody Stops Covid-19 Variants
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2.
-
Synthetic Bio Companies Partner on Therapeutic Microbes
A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria.
-
Natural Killer Cells Stop Ovarian Cancer in Preclinical Test
Results from a lab study show engineered immune system cells sharply reduce tumors and extend survival in mice grafted with a type of ovarian cancer.
-
Infographic – Biotech Index Plunge Continues in Q1
Since the beginning of 2022, the Nasdaq Biotechnology Index, an indicator of investor sentiment in the industry, has declined about 10 percent.
-
Biotech, Synthetic Bio Companies Partner on T-Cell Therapies
A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics.
-
Trial to Test AI-Designed Cancer Antibody Therapy
A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms.
-
Antimicrobial Resistance Fund Invests in Two Biotechs
A pharmaceutical industry venture fund is investing in two developers of new treatments for bacterial infections becoming resistant to antibiotics.
-
NIH Funding Nanoparticle Gene Therapy for Opioid Disorder
National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder.